Disease Info Card

Cataplexy And Narcolepsy

Information about Cataplexy And Narcolepsy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cataplexy And Narcolepsy

Most recent studies have shown that Cataplexy And Narcolepsy shares some biological mechanisms with apnea, autoimmune-reaction, behavior-disorders, cataplexy, depressive-disorder, disorders-of-excessive-somnolence, excessive-daytime-somnolence, hallucinations, hypersomnolence-idiopathic, hypnagogic-hallucination, malnutrition, narcolepsy, narcolepsy-without-cataplexy, nervous-system-disorder, nervousness, primary-hypersomnia, sleep-apnea-syndromes, sleep-attacks, sleep-disorders, sleep-paralysis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cataplexy And Narcolepsy, and have been seen in publications frequently: Aging, Brain Development, Cell Activation, Cell Death, Circadian Rhythm, Energy Homeostasis, Feeding Behavior, Growth Hormone Secretion, Habituation, Hormone Secretion, Immune Response, Innervation, Localization, Pathogenesis, Prolactin Secretion, Reflex, Secretion, Synaptic Transmission, T Cell Activation, Translation

Quite a number of genes have been found to play important roles in Cataplexy And Narcolepsy, such as ACHE, CHN1, CSF2, GNL3, HCRT, HLA-DQB1, HLA-DQB2, HLA-DRB4, LAMC2, LEP, LIFR, PMCH, PNPLA6, POMC, REM1, SLC17A7, SLC18A3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.